This trial is investigating the feasibility of returning whole genome sequencing results within 8 weeks of a biliary tract cancer tumor biopsy, in order to identify actionable molecular alterations that may improve clinical outcomes.
1 Primary · 5 Secondary · Reporting Duration: 4 years
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Tumour and germline molecular profiling · No Placebo Group · N/A
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: